MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12951-026-04711-9

Медицинская библиотека · Journal of nanobiotechnology · 2026

Targeting ferroptosis induction via nanomaterials in hepatocellular carcinoma: an insight into mechanism and therapeutic potential.

Song Yang, Yu Shasha, Chen Fengshou, Wang Yizi, Zhang Haishan, Qu Xiaohan

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, continues to be a leading cause of cancer-related deaths worldwide, despite the development of new treatment options, including systemic regimens, locoregional treatments, transplantation, and resection. Significant etiological and genetic heterogeneity, an immunosuppressive tumor microenvironment, dose-limiting toxicities, and high rates of post-treatment recurrence continue to inhibit robust responses. Given the crucial role of the liver in iron metabolism and oxidative homeostasis, ferroptosis-a controlled, iron-dependent cell death triggered by glutathione depletion, GPX4 inactivation, and lipid peroxidation, has become a potential therapeutic vulnerability in HCC. However, the risk of off-target oxidative damage, insufficient intratumoral transport, and the poor solubility and pharmacokinetics of small-molecule ferroptotic inducers limit the therapeutic application of ferroptosis induction.The current review is novel to the best of our knowledge, focusing on a targeted and current synthesis of nanomaterials delivering ferroptotic inducers in order to induce ferroptosis in HCC as a next-generation therapeutic paradigm. We describe how constructed nanoplatforms allow for spatiotemporally controlled ROS formation and iron-catalyzed lipid peroxidation, while also improving tumor-selective accumulation of ferroptosis triggers, extending circulation, and improving stability. In order to transform ferroptotic stress into antitumor immunity, we highlight ferroptotic inducing nanomaterials that co-deliver ferroptosis inducers alongwith chemotherapeutics or photothermal/photodynamic agents, and immunomodulatory designs that invoke innate immune pathways like cGAS-STING. This work establishes ferroptosis-inducing nanomedicine as a new and quickly developing field with the potential to overcome resistance, expand therapeutic windows, and enhance long-term outcomes for patients with HCC.

Для цитирования: Song Yang, Yu Shasha, Chen Fengshou, Wang Yizi, Zhang Haishan, Qu Xiaohan. Targeting ferroptosis induction via nanomaterials in hepatocellular carcinoma: an insight into mechanism and therapeutic potential.. Journal of nanobiotechnology. 2026. DOI: 10.1186/s12951-026-04711-9.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.